Capricor Therapeutics, Inc. (CAPR) Social Stream
Capricor Therapeutics Inc (CAPR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CAPR.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 12 months, CAPR's average price target has gone up $3.
CAPR reports an average of 184.36% for its upside potential over the past 34 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CAPR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CAPR as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Capricor Therapeutics Inc's number of analysts covering the stock is greater than 9.38% of them.
- In the context of all US stocks, Capricor Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 185.25% of them.
- In the context of all US stocks, Capricor Therapeutics Inc's average analyst price target is higher than 28.8% of them.
- In terms of how Capricor Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 55.3% of that group.
Is CAPR a Buy, Hold or Sell? See the POWR Ratings now!